BioLife Solutions Announces Closing of Stirling Ultracold Acquisition and Expanded Partnership with Leading Global BioPharma CDMO

May 3, 2021

BOTHELL, Washington – BioLife Solutions, Inc. (NASDAQ: BLFS)

(“BioLife” or the “Company”), a leading developer and supplier of a portfolio of class-defining bioproduction products and services for cell and gene therapies and the broader biopharma market, today announced that it has closed the previously announced acquisition of Stirling Ultracold (“Stirling”), a privately held manufacturer of ultra-low temperature (“ULT”) mechanical freezers.  BioLife issued 6,646,870 shares of common stock in exchange for 100% of the outstanding shares of Stirling.

Read more of this press release on Stirling Ultracold’s website:

Also, at Columbus Business First: